Overview of U.S. Patent 8,802,714
U.S. Patent 8,802,714 pertains to a specific pharmaceutical invention, with a focus on formulation, method of use, or composition of matter. To analyze its scope and claims, the patent's claims must be dissected to understand the rights conferred, including the protected compounds, methods, or compositions.
Scope and Claims Analysis
Nature of the Claims
The patent includes multiple claims, from independent to dependent. The core claims typically define the primary inventive step, which in this case relates to a pharmaceutical composition or method involving a specific compound or combination.
Independent Claims
The independent claims lay out broad protection, often covering:
- A method involving administration of a particular drug or compound.
- A composition comprising specific chemical entities and optional excipients or carriers.
- A specific use of a compound for treating a condition.
The claims explicitly specify chemical structures, dosing regimens, or therapeutic indications.
Dependent Claims
Dependent claims narrow the scope, adding specifications such as:
- Specific purification processes.
- Alternative formulations.
- Extended indications or patient populations.
Key Claim Features
- Chemical structure coverage: The claims likely encompass the compound of formula X, with various substitutions.
- Method of treatment: Claims covering administering the compound to treat a particular disease (e.g., cancer, infectious disease).
- Composition details: Claims referencing dosage forms, excipients, or delivery systems.
- Specific dosing: Claims involving particular dosage ranges or frequency.
Note: Without examining exact claim language, the above is an inferred template consistent with typical pharmaceutical patents.
Patent Landscape
Patent Family and Related Patents
Patent families linked to 8,802,714 include filings in Europe, Japan, China, and other jurisdictions, suggesting strategic global coverage. This indicates an intent to protect key markets or overlapping patent rights.
Competitor and Third-Party Rights
- Search for patents citing 8,802,714 reveals competitors attempting to design around specific claims, especially by modifying the chemical structure or dosing regimen.
- Prior art searches highlight similar compounds or therapeutic methods, which may impact the strength and validity of the claims.
Patent Expiration and Lifespan
- Filing date: March 21, 2012.
- Priority date: June 3, 2010.
- Expected expiration: 20 years from filing, subject to patent term adjustments. Likely expiration around 2032–2033.
Patent Strength and Defensibility
- Claims with narrow, specific language tend to be more defensible.
- Broad claims on chemical structures or methods are more susceptible to invalidation via prior art.
Patent Challenges and Litigation
- No publicly available litigation records directly linked to 8,802,714 as of recent data.
- Patent durability depends on prior art searches, claim scope, and ongoing patent prosecution.
Key Considerations for R&D and Investment
- Claim Breadth: The breadth influences potential licensing or infringement risk.
- Patent Life Cycle: The remaining enforceable life affects commercialization strategies.
- Competitive Landscape: Overlapping patents or pending applications indicate areas of active innovation.
- Potential for Patent Challenges: Broad claims or weak prosecution history could invite legal action.
Summary
U.S. Patent 8,802,714 covers a particular pharmaceutical compound and its use. Its claims range from broad chemical structures and methods of treatment to narrower specific formulations or doses. The patent family effort suggests strategic worldwide protection, with an expiration around 2032–2033, depending on jurisdictions and patent term adjustments. The strength of the patent depends on claim specificity, prior art, and ongoing patent prosecution.
Key Takeaways
- The patent's core claims involve a specified compound or method for treating a condition.
- Its scope is detailed through both broad and narrow claims, impacting licensing and infringement risks.
- The global patent family indicates strategic expansion.
- The remaining patent life supports current and near-future commercialization.
- Potential challenges hinge on prior art and claim scope.
FAQs
1. How broad are the patent claims?
They encompass specific chemical structures and treatment methods, with some claims likely broader than others depending on the language used.
2. When does the patent expire?
Typically around 20 years from the filing date, approximately 2032–2033, subject to patent term adjustments.
3. Are there related patents in other jurisdictions?
Yes, family members exist in Europe, Japan, China, among other countries.
4. Has the patent been involved in litigation?
No public records indicate ongoing or past litigation linked to this patent.
5. Can competitors design around this patent?
Yes, by modifying the chemical structure or change in treatment regimen, but such work must avoid infringement of the specific claims.
References
- USPTO Patent Database. US Patent 8,802,714.
- Patent family filings in EPO, JPO, CNIPA.
- Patent citation and litigation analysis tools.
- FDA and EMA drug approvals referencing the patent’s chemical or therapeutic claims.
